How many children around the world have attention deficit hyperactivity disorder (ADHD)? Is ADHD a creation of permissive Western culture rarely seen outside North America? Do world regions with elevated ADHD rates hold the key to causation?
Also at stake is the potential for scientists to exploit geographic variation in ADHD's prevalence to yield new information concerning its causes, which currently remain frustratingly unknown. Geographic comparisons are a powerful tool for investigating the etiology of disorders. In the first epidemiological study ever conducted, John Snow compared rates of cholera across areas of London during the 1854 cholera epidemic. Going against the then-prevalent -miasma‖ theory, which stipulated that diseases are carried by foul air, Snow surveyed residents about their source of drinking water and, using simple statistics, discovered that cholera cases were clustered around one particular water pump. This discovery lead to the closing of the infected pump and prevented new cases. Moreover, although Snow was unable to identify the water-borne particles that cause cholera, his finding advanced the germ theory of disease (3).
Contemporary examples show that when populations vary on their exposure to risk factors, geographic comparisons of disorder rates can generate new hypotheses about etiology. High rates of asthma and allergy in developed Western countries, compared to developing countries, generated new hypotheses about the etiology of respiratory disorders (e.g., childhood exposure to antibiotics, exposure to dust mite allergens, overly hygienic life styles) (4). In psychiatry, geographic comparisons reveal that the prevalence of schizophrenia in urban locations is more than double that in rural locations (5) . This observation generated new hypotheses now subject to intense research (e.g., urban social isolation, infectious exposure exacerbated by urban crowding). In child psychiatry, geographic comparisons discredited the hypothesis that well-baby immunizations cause autism; countries with versus without the vaccine have the same prevalence of autism (6) .
Considering ADHD, high-prevalence countries could offer clues to etiology, whereas inserm-00165604, version 1 -10 Nov 2009 low-prevalence countries could share protective factors that reduce the prevalence of ADHD. However, before looking for geographic clues to causation, it is necessary to rule out the alternative explanation for geographic differences in prevalence: methodological The last step tested whether the different prevalence rates across studies could be accounted for by different methodologies. Methodological features were coded for each study, including sample size, response rate, information source (e.g., parents, teachers, children), and whether diagnosis followed the ICD (8) or the DSM. The main finding was that the difference in ADHD prevalence between North America and Europe was explained by methodology. Most important, all North American researchers had followed the DSM, whereas many European researchers had preferred the ICD. What's the difference? The ICD-10 strictly requires that a child must show symptoms in all three dimensions (inattention, hyperactivity, and impulsivity) and must meet all criteria at home and at school. The ICD-10 also excludes children with co-occurring disorders.
DSM-IV is more lenient. It is possible to diagnose a child who shows symptoms in only one dimension (inattention). Some impairing symptoms-but not all-must be shown at home and at school. DSM-IV allows diagnosing ADHD alongside co-occurring disorders. Polanczyk et al. (this issue) concluded that geographic variation in the reported prevalence of ADHD is mainly explained by methodological foibles such as these diagnostic rules. Supporting this conclusion, a multisite trial study reported that using a uniform diagnostic protocol yields ADHD patients who are highly similar across clinics in Africa, Australia, Europe, and North America (9).
The finding of Polanczyk and colleagues of a uniform prevalence rate worldwide attests that ADHD is probably not caused by the avarice of the American psychiatric profession or by permissive Western culture and that reducing our avarice and inserm-00165604, version 1 -10 Nov 2009 permissiveness will not make ADHD disappear (1) . A uniform prevalence rate worldwide also suggests, disappointingly, that geographical variation will not provide fresh clues to the causation of ADHD. Because there is no causal biomarker with which to diagnose ADHD, the diagnosis remains syndromebased. Thus, becoming an identified ADHD patient is partly a function of the gap between a child's behavior and the expectations of the adults in his or her world about how children ought to behave (2) . This gap is encoded differently in DSM-IV, which identifies more children with ADHD, versus ICD-10, which identifies fewer. The question is whether DSM-IV overidentifies ADHD or ICD-10 underidentifies ADHD. The answer matters. Excess medical costs per ADHD patient, relative to same-age children, have been estimated at near $1,000 per child per year for hospitalization, primary care office visits, outpatient mental health visits, and medications (10) . Thus, even a small shift in the population prevalence of diagnosed ADHD could have important fiscal implications for institutions involved in the treatment of ADHD.
Nosologists are working toward a more unified approach between DSM-V and ICD-11; there is much good work to be done.
